ArticleFrontiers in neurology
A multimodal machine learning model for predicting postoperative worsening of FOGQ in Parkinson's disease following STN-DBS.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate a multimodal machine learning model to predict postoperative worsening of freezing of gait questionnaire (FOGQ) scores in patients with Parkinson's disease (PD) undergoing subthalamic nucleus deep brain stimulation (STN-DBS). Methods: This retrospective study analyzed data from 134 patients with PD who underwent bilateral STN-DBS. The model integrated four data modalities: clinical scale assessments, structural neuroimaging features derived from voxel-based morphometry (VBM), stereotactic electrode localization data via Lead-DBS analysis, and radiomics features extracted from preoperative MRI. Following standardization, feature selection was conducted using LASSO, Boruta and recursive feature elimination with cross-validation (RFECV) methods to identify the most relevant predictors. Multiple machine learning algorithms were evaluated. Model development and internal validation were conducted using a 5-fold nested cross-validation framework. Model performance was assessed using ROC curves, calibration curves, and decision curve analysis, and model interpretability was analyzed using SHAP values. Results: The LightGBM model achieved the highest AUC of 0.917 for predicting FOGQ deterioration. The analysis emphasized the importance of multimodal data integration, combining clinical, structural, and radiomic features to enhance predictive accuracy. Conclusion: This multimodal LightGBM model achieved robust discrimination between patients with and without postoperative FOGQ deterioration, highlighting the value of integrating clinical, structural, and radiomic features for preoperative risk stratification in PD patients undergoing STN-DBS. These findings may inform personalized patient selection, early identification of high-risk individuals, and treatment planning, though external validation in prospective multicenter cohorts remains a necessary next step.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.